Cardiac Biotech Solutions, Inc. (CBSC)
0.04
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Cardiac Biotech Solutions Total Assets (Quarterly) : 0.5053M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5053M |
| March 31, 2026 | 0.4941M |
| December 31, 2025 | 0.3773M |
| September 30, 2025 | 0.4518M |
| June 30, 2025 | 0.1732M |
| March 31, 2025 | 0.1674M |
| December 31, 2024 | 0.2243M |
| September 30, 2024 | 0.2767M |
| June 30, 2024 | 0.1839M |
| March 31, 2024 | 0.3004M |
| December 31, 2023 | 0.4901M |
| September 30, 2023 | 0.1603M |
| June 30, 2023 | 0.1859M |
| March 31, 2023 | 0.3048M |
| December 31, 2022 | 0.1728M |
| September 30, 2022 | 0.2871M |
| June 30, 2022 | 0.2535M |
| March 31, 2022 | 0.654M |
| December 31, 2021 | 2.112M |
| September 30, 2021 | 1.837M |
| June 30, 2021 | 1.712M |
| Date | Value |
|---|---|
| March 31, 2021 | 0.3118M |
| December 31, 2020 | 18.05M |
| September 30, 2020 | 17.57M |
| June 30, 2020 | 17.45M |
| March 31, 2020 | 0.1086M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | 0.0251M |
| March 31, 2019 | 0.036M |
| December 31, 2018 | 0.0632M |
| September 30, 2018 | 0.0734M |
| June 30, 2018 | 0.0683M |
| March 31, 2018 | 0.0606M |
| December 31, 2017 | 0.1877M |
| September 30, 2017 | 0.2273M |
| June 30, 2017 | 0.0619M |
| March 31, 2017 | 0.0676M |
| December 31, 2016 | 2.231M |
| September 30, 2016 | 2.237M |
| June 30, 2016 | 2.211M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vyome Holdings, Inc. | 9.176M |
| Abbott Laboratories | 109.22B |
| AngioDynamics, Inc. | 267.16M |
| Alphatec Holdings, Inc. | 791.03M |
| AtriCure, Inc. | 676.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.726M |
| Shareholders Equity (Quarterly) | -2.221M |
| Debt to Equity Ratio | -0.2375 |
| Current Ratio | 0.2327 |
| Net Debt Paydown Yield | -1.03% |